查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1561649

免疫組織化學市場報告（按產品（抗體、設備、試劑、試劑盒）、應用（診斷、藥物測試）、最終用途（醫院和診斷實驗室、研究機構等）和地區 2024-2032

Immunohistochemistry Market Report by Product (Antibodies, Equipment, Reagents, Kits), Application (Diagnostics, Drug Testing), End Use (Hospitals and Diagnostic Laboratories, Research Institutes, and Others), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

2023年全球免疫組化市場規模達26IMARC Group美元。慢性病盛行率的上升、對個人化藥物的需求不斷增加、診斷技術的顯著進步、醫療基礎設施投資的增加以及人口老化的加劇是推動市場成長的一些主要因素。

免疫組織化學市場分析：

  • 主要市場驅動力：傳染病和慢性病發病率不斷上升，需要先進的診斷解決方案，這是市場的主要驅動力。很大程度上依賴生物標記識別的個人化醫療的廣泛採用進一步刺激了對免疫組織化學的需求。診斷技術的重大技術進步提高了免疫組織化學測試的準確性和效率。
  • 主要市場趨勢：先進成像技術的日益整合和自動化以提高診斷吞吐量和準確性是市場的主要趨勢之一。伴隨診斷和精準醫學的日益轉變強調個人化治療策略。多重檢測的不斷發展允許同時檢測多種生物標記，從而提高效率。
  • 地理趨勢：北美佔據免疫組織化學市場最大的地區。加拿大和美國對癌症研究和診斷進步的高度重視正在推動市場成長。這主要是由於大量的醫療保健支出和完善的醫療基礎設施。個人化醫療和基於生物標記的測試的廣泛採用，特別是在腫瘤學領域，正在推動整個地區的市場成長。
  • 競爭格局：免疫組織化學產業的一些主要市場參與者包括Abcam plc、安捷倫科技公司、Beckman Coulter Inc.（丹納赫）、Becton Dickinson and Company、Bio SB Inc.、Bio-Rad Laboratories Inc.、Bio - Techne Corporation、Cell Signaling Technology Inc.、F. Hoffmann-La Roche AG、Merck KGaA、Perkinelmer Inc. 和 Thermo Fisher Scientific Inc. 等。
  • 挑戰與機會：市場面臨各種挑戰，包括與先進成像系統和試劑相關的高成本、缺乏能夠解釋複雜免疫組化資料的熟練專業人員以及對產品核准的嚴格監管要求。然而，市場面臨著一些機遇，例如對個人化醫療和標靶療法的需求不斷成長，這些療法嚴重依賴免疫組織化學標記來製定有效的治療計劃。

免疫組織化學市場趨勢：

慢性病盛行率增加

包括癌症在內的慢性病發生率不斷上升，推動了準確診斷和預後工具的需求。免疫組織化學對於檢測癌症和其他疾病的生物標記至關重要，有助於精確的診斷和治療計劃。根據世界衛生組織（WHO）公佈的資料，2022年估計將新增癌症病例2,000萬例，死亡人數970萬人。據估計，癌症診斷後 5 年內存活的人數為 5,350 萬人。大約五分之一的人在一生中罹患癌症，大約九分之一的男性和十二分之一的女性死於疾病。主要參與者透過推出更有效的產品和服務來適當地應對這種激增。例如，2024 年 4 月，生命科學研究和臨床診斷產品領域的全球領導者 Bio-Rad Laboratories, Inc. 宣布推出首款超靈敏多重數位 PCR 檢測方法 ddPLEX ESR1 突變檢測試劑盒。該檢測擴展了該公司針對腫瘤市場的微滴數位 PCR (ddPCR) 產品，其中高靈敏度和多重突變檢測檢測有助於轉化研究、治療選擇和疾病監測。預計這將進一步提高未來幾年免疫組織化學市場的預測。

重大技術進步

顯微鏡、染色技術和數位成像方面不斷發展的技術創新提高了免疫組織化學程序的有效性和效率，使其成為詳細組織分析的首選方法。例如，2023 年5 月，全球領先的醫療技術公司BD（Becton Dickinson 公司）宣佈在全球範圍內商業推出一款新的世界銷售分類儀器，該儀器提供兩項突破性技術，使研究人員能夠發現有關銷售的更詳細資訊以前在傳統流式細胞術實驗中是看不見的。借助 BD CellView 影像技術，研究人員可以看到單一細胞的詳細顯微影像，並根據視覺特徵進行高速分類，以即時確認見解。借助 BD SpectalFX 技術，研究人員可以實現全光譜細胞分選，再加上新的模組化光學架構和系統感知演算法帶來的擴展性能，從而在簡化的工作流程中執行高參數實驗。

日益關注個人化醫療

個人化醫療（尤其是腫瘤學）的日益轉變，正在推動對免疫組織化學的需求，以識別特定的分子標靶並根據個別患者的情況量身定做治療方案，從而改善治療結果。例如，2023 年6 月，全球科學服務領導者賽默飛世爾科技(Thermo Fisher Scientific) 宣布推出Gibco OncoPro 腫瘤類培養基試劑盒，這是首款專為擴增患者來源的類腫瘤或癌症類器官而開發的市售培養基，來自多種癌症適應症。同樣，2023 年 1 月，班加羅爾阿波羅癌症中心推出了印度首個人工智慧精準腫瘤中心 (POC)，這是一項重大舉措，將大幅提高腫瘤護理的品質。該中心將利用人工智慧提供的巨大可能性，幫助腫瘤學家、患者和照護者在有限的時間內獲得最佳結果。這正在影響全球免疫組織化學市場的收入。

免疫組織化學市場細分：

IMARC Group提供了每個細分市場的主要趨勢的分析，以及 2024-2032 年全球、區域和國家層面的預測。我們的報告根據產品、應用和最終用途對市場進行了分類。

按產品分類：

  • 抗體
    • 一抗
    • 二抗
  • 裝置
    • 玻片染色系統
    • 組織微陣列
    • 組織處理系統
    • 玻片掃描儀
    • 其他
  • 試劑
    • 組織學染色
    • 封閉血清和試劑
    • 顯色底物
    • 固定試劑
    • 穩定劑
    • 有機溶劑
    • 蛋白水解酶
    • 稀釋劑
  • 套件

抗體佔大部分市場佔有率

該報告根據產品提供了詳細的市場細分和分析。這包括抗體（初級和次級）、設備（玻片染色系統、組織微陣列、組織處理系統、玻片掃描儀等）、試劑（組織學染色劑、封閉血清和試劑、顯色底物、固定試劑、穩定劑、有機溶劑、蛋白水解酶和稀釋劑）和試劑盒。根據該報告，抗體代表了最大的部分。

對疾病診斷和研究的需求不斷成長，特別是癌症和傳染病，這提高了對特異性抗體的需求。抗體工程的不斷創新提高了特異性和敏感性，從而提高了診斷準確性。不斷擴大的生物醫學研究需要多種抗體來進行詳細的細胞和分子研究。個人化治療方法需要精確的生物標記識別，從而促進標靶抗體的使用。例如，2023年8月，Regeneron Pharmaceuticals, Inc.宣布生物醫學高級研究與開發（BARDA）機構已與Regeneron達成協議，支持下一代COVID-19單株抗體的臨床開發、臨床生產和監管許可流程用於預防SARS-CoV-2 感染的抗體療法。

按應用分類：

  • 診斷
    • 癌症
    • 傳染病
    • 心血管疾病
    • 自體免疫疾病
    • 糖尿病
    • 腎臟病
  • 藥物檢測

診斷佔產業最大佔有率

報告還提供了基於應用程式的詳細市場細分和分析。這包括診斷（癌症、傳染病、心血管疾病、自體免疫疾病、糖尿病和腎臟疾病）和藥物測試。報告稱，診斷佔據了最大的市場佔有率。

心血管疾病、傳染病、癌症、自體免疫疾病、腎臟病和糖尿病病例的增加需要先進的診斷方法。與此一致的是，人們更加關注基於透過免疫組織化學檢測到的特定生物標記的個人化治療計劃。染色技術和新興技術的顯著改進提高了疾病診斷的準確性和效率。不斷成長的研究活動需要詳細的細胞分析，促進免疫組織化學在理解疾病機制和病理學方面的應用。這進一步推動了免疫組織化學市場對診斷的需求成長。

按最終用途細分：

  • 醫院和診斷實驗室
  • 研究所
  • 其他

醫院和診斷實驗室代表領先的細分市場

該報告根據最終用途對市場進行了詳細的細分和分析。這包括醫院和診斷實驗室、研究機構等。根據該報告，醫院和診斷實驗室代表了最大的部分。

慢性病（尤其是癌症）發生率的上升推動了對免疫組織化學等精確診斷工具的需求，以準確識別和分類疾病狀態。數位成像系統和染色技術的重大創新增強了免疫組織化學的診斷能力和通量，使其對臨床環境更具吸引力。人們越來越關注診斷過程中遵守高品質和監管標準，因此需要免疫組織化學等可靠的技術。對醫療保健基礎設施和診斷服務的投資不斷增加，促進了已開發市場和新興市場採用免疫組織化學等先進診斷方法。

按地區分類：

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

北美市場領先，佔據最大的免疫組化市場佔有率

該報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告稱，北美是免疫組織化學最大的區域市場。

癌症和其他慢性病病例的增加推動了對免疫組織化學等精確診斷方法的需求，以識別有效治療的生物標記物，這影響了整個地區的市場成長。完善的醫療設施和雄厚的研發資金（R&D）正在促進先進診斷技術的採用。根據美國國家醫學圖書館的資料，預計2024年美國將新增2,001,140例癌症病例，611,720例癌症死亡。到 2021 年，癌症死亡率持續下降，自 1991 年以來，由於吸菸減少、某些癌症的早期檢測以及輔助和轉移治療方案的改進，癌症死亡率避免了超過 400 萬人死亡。

（請注意，這只是關鍵參與者的部分列表，報告中提供了完整列表。）

  • 該市場競爭激烈，安捷倫科技、賽默飛世爾科技和羅氏診斷等主要廠商佔據主導地位。這些參與者專注於創新和策略合作夥伴關係，以增強其產品組合。 Merk Group、Bio-Rad Laboratories 和 Danaher Corporation 等其他重要公司強調透過合作和收購擴大其全球足跡。 2023 年 2 月，安捷倫科技公司推出了一款整合解決方案，將 xCELLigence RTCA HT 平台與 Bio Tek BioSpa 8 自動培養箱結合。這項新開發提供了更高水準的工作流程自動化，允許進一步創建用於免疫腫瘤學的無標記高通量效力測定以及針對疫苗市場的高通量病毒細胞病變效應（CPE）測定。

免疫組織化學市場新聞：

  • 2023 年 8 月，全球科技供應商丹納赫簽署了最終協議，以 57 億美元的價格收購英國蛋白質耗材供應商 Abcam 的所有已發行股份。
  • 2024 年1 月，安捷倫科技公司宣布與Incyte 達成協議，該協議將匯集安捷倫在伴隨診斷(CDx) 開發方面的專業知識和良好記錄，以支持Incyte 血液學和腫瘤學產品組合商業化的發展。
  • 2022 年 6 月，領先的科技公司默克宣布與安捷倫科技公司合作，推動流程分析技術 (PAT)。 PAT 受到全球監管機構的大力鼓勵，是即時發布和生物處理 4.0 的關鍵推動者。

本報告回答的關鍵問題：

  • 迄今為止，全球免疫組化市場表現如何，未來幾年將如何表現？
  • 全球免疫組化市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球免疫組織化學市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的免疫組織化學市場？
  • 基於產品的市場區隔是什麼？
  • 免疫組化市場上最具吸引力的產品是什麼？
  • 基於應用的市場區隔是什麼？
  • 免疫組化市場中最具吸引力的應用是什麼？
  • 根據最終用途分類的市場是怎樣的？
  • 免疫組織化學市場中最具吸引力的最終用途是什麼？
  • 市場競爭結構如何？
  • 全球免疫組化市場的主要參與者/公司有哪些？

本報告回答的關鍵問題：

  • 迄今為止，全球免疫組化市場表現如何，未來幾年將如何表現？
  • 全球免疫組化市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球免疫組織化學市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的免疫組織化學市場？
  • 基於產品的市場區隔是什麼？
  • 免疫組化市場上最具吸引力的產品是什麼？
  • 基於應用的市場區隔是什麼？
  • 免疫組化市場中最具吸引力的應用是什麼？
  • 根據最終用途分類的市場是怎樣的？
  • 免疫組織化學市場中最具吸引力的最終用途是什麼？
  • 市場競爭結構如何？
  • 全球免疫組化市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球免疫組織化學市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品

  • 抗體
    • 市場趨勢
    • 關鍵環節
      • 一抗
      • 二抗
    • 市場預測
  • 裝置
    • 市場趨勢
    • 關鍵環節
      • 玻片染色系統
      • 組織微陣列
      • 組織處理系統
      • 玻片掃描儀
      • 其他
    • 市場預測
  • 試劑
    • 市場趨勢
    • 關鍵環節
      • 組織學染色
      • 封閉血清和試劑
      • 顯色底物
      • 固定試劑
      • 穩定劑
      • 有機溶劑
      • 蛋白水解酶
      • 稀釋劑
    • 市場預測
  • 套件
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：按應用

  • 診斷
    • 市場趨勢
    • 關鍵環節
      • 癌症
      • 傳染病
      • 心血管疾病
      • 自體免疫疾病
      • 糖尿病
      • 腎臟病
    • 市場預測
  • 藥物檢測
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：最終用途別

  • 醫院和診斷實驗室
    • 市場趨勢
    • 市場預測
  • 研究所
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abcam plc
    • Agilent Technologies Inc.
    • Beckman Coulter Inc. (Danaher Corporation)
    • Becton Dickinson and Company
    • Bio SB Inc.
    • Bio-Rad Laboratories Inc.
    • Bio-Techne Corporation
    • Cell Signaling Technology Inc.
    • F. Hoffmann-La Roche AG
    • Merck KGaA
    • Perkinelmer Inc.
    • Thermo Fisher Scientific Inc.
Product Code: SR112024A4404

The global immunohistochemistry market size reached US$ 2.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.9 Billion by 2032, exhibiting a growth rate (CAGR) of 6.8% during 2024-2032. The rising prevalence of chronic diseases, the increasing demand for personalized medicines, significant advancements in diagnostic techniques, growing investments in healthcare infrastructure, and the rising aging population are some of the major factors propelling the growth of the market.

Immunohistochemistry Market Analysis:

  • Major Market Drivers: The growing incidence of infectious and chronic diseases which necessitate advanced diagnostic solutions represent the major drivers of the market. The widespread adoption of personalized medicine, which relies heavily on biomarker identification is further stimulating the demand for immunohistochemistry. Significant technological advancements in diagnostic techniques enhance the accuracy and efficiency of immunohistochemistry tests.
  • Key Market Trends: The increasing integration and automation of advanced imaging technologies to enhance diagnostic throughput and accuracy represents one of the key trends in the market. The rising shift toward companion diagnostic and precision medicine, emphasizes personalized treatment strategies. The growing development of multiplex assays allows simultaneous detection of multiple biomarkers thus increasing efficiency.
  • Geographical Trends: North America accounts for the largest region in the immunohistochemistry market. The strong emphasis on cancer research and diagnostic advancements in Canada and the US is driving the market growth. This is primarily due to the substantial healthcare spending and well-established medical infrastructure. The widespread adoption of personalized medicine and biomarker-based testing, particularly in oncology is fueling the market growth across the region.
  • Competitive Landscape: Some of the major market players in the immunohistochemistry industry include Abcam plc, Agilent Technologies Inc., Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, Bio SB Inc., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, Merck KGaA, Perkinelmer Inc. and Thermo Fisher Scientific Inc., among many others.
  • Challenges and Opportunities: The market faces various challenges in the market including high costs associated with advanced imaging systems and reagents, a lack of skilled professionals capable of interpreting complex immunohistochemical data, and strict regulatory requirements for product approvals. However, the market faces several opportunities such as the rising demand for personalized medicine and targeted therapies that rely heavily on immunohistochemical markers for effective treatment planning.

Immunohistochemistry Market Trends:

Increasing Prevalence of Chronic Diseases

The rising incidence of chronic diseases including cancer is driving the demand for accurate diagnostic and prognostic tools. Immunohistochemistry is crucial for detecting biomarkers in cancer and other diseases, thus aiding in precise diagnosis and treatment planning. According to data published by the World Health Organization (WHO), in 2022, there were an estimated 20 million new cancer cases and 9.7 million deaths. The estimated number of people who were alive within 5 years following a cancer diagnosis was 53.5 million. About 1 in 5 people develop cancer in their lifetime, and approximately 1 in 9 men and 1 in 12 women die from the disease. This surge is aptly met by the key players by introducing more effective products and services. For instance, in April 2024, Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, announced the launch of its first ultrasensitive multiplexed digital PCR assay, the ddPLEX ESR1 Mutation Detection Kit. The assay expands the company's Droplet Digital PCR (ddPCR) offering for the oncology market, where highly sensitive and multiplexed mutation detection assays aid translational research, therapy selection, and disease monitoring. This is further expected to boost the immunohistochemistry market forecast over the coming years.

Significant Technological Advancement

The growing technological innovations in microscopy, staining techniques, and digital imaging enhance the effectiveness and efficiency of immunohistochemistry procedures, thereby making it a preferred method for detailed tissue analysis. For instance, in May 2023, BD (Becton, Dickinson, and Company), a leading global medical technology company, announced the worldwide commercial launch of a new world sales sorting instrument offering two breakthrough technologies that enable researchers to uncover more detailed information about sales that were previously invisible in traditional flow cytometry experiments. With BD CellView Image Technology, researchers can see detailed microscopic images of individual cells and sort at high speeds based on visual characteristics to confirm insights in real time. With BD SpectalFX Technology, researchers can achieve full spectrum cell sorting, coupled with expanded performance enabled by a new modular optical architecture and system-aware algorithms, to perform high parameter experiments within a simplified workflow.

Rising Focus on Personalized Medicine

The increasing shift toward personalized medicine, especially in oncology, is driving the need for immunohistochemistry to identify specific molecular targets and tailor treatments to individual patient profiles, thus improving therapeutic outcomes. For instance, in June 2023, Thermo Fisher Scientific, the world leader in serving science, announced the launch of Gibco OncoPro Tumor Roid Culture Medium Kit, the first commercially available culture medium specifically developed for the expansion of patient-derived tumoroids, or cancer organoids, from multiple cancer indications. Similarly, in January 2023, Apollo Cancer Center, Bengaluru, launched India's first AI Precision Oncology Center (POC) in a significant move that will substantially enhance the quality of oncology care. The Center will help the oncologists, patients, and caregivers to arrive at the best possible results in a time-bound manner the enormous possibilities offered by AI. This is influencing the immunohistochemistry market revenue across the globe.

Immunohistochemistry Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, application, and end-use.

Breakup by Product:

  • Antibodies
    • Primary Antibodies
    • Secondary Antibodies
  • Equipment
    • Slide Staining Systems
    • Tissue Microarrays
    • Tissue Processing Systems
    • Slide Scanners
    • Others
  • Reagents
    • Histological Stains
    • Blocking sera and Reagents
    • Chromogenic Substrates
    • Fixation Reagents
    • Stabilizers
    • Organic Solvents
    • Proteolytic Enzymes
    • Diluents
  • Kits

Antibodies accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product. This includes antibodies (primary and secondary), equipment (slide staining systems, tissue microarrays, tissue processing systems, slide scanners, and others), reagents (histological stains, blocking Sera and Reagents, chromogenic substrates, fixation reagents, stabilizers, organic solvents, proteolytic enzymes, and diluents), and kits. According to the report, Antibodies represented the largest segment.

The increasing need for disease diagnosis and research, especially cancers and infectious diseases is elevating the demand for specific antibodies. The rising innovations in antibody engineering improve specificity and sensitivity, enhancing diagnostic accuracy. The expanding biomedical research necessitates diverse antibodies for detailed cellular and molecular studies. Personalized treatment approaches require precise biomarker identification, boosting the use of targeted antibodies. For instance, in August 2023, Regeneron Pharmaceuticals, Inc. announced that the Biomedical Advanced Research and Development (BARDA)authority has agreed with Regeneron to support clinical development, clinical manufacturing, and the regulatory licensure process of on next-generation COVID-19 monoclonal antibody therapy for the prevention of SARS-CoV-2 infection.

Breakup by Application:

  • Diagnostics
    • Cancer
    • Infectious Diseases
    • Cardiovascular Diseases
    • Autoimmune Diseases
    • Diabetes Mellitus
    • Nephrological Diseases
  • Drug Testing

Diagnostics holds the largest share of the industry

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes diagnostics (cancer, infectious diseases, cardiovascular diseases, autoimmune diseases, diabetes mellitus, and nephrological diseases) and drug testing. According to the report, diagnostics accounted for the largest market share.

The increasing cases of cardiovascular, infectious diseases, cancer, autoimmune, nephrological conditions, and diabetes necessitate advanced diagnostic methods. In line with this, the enhancing focus on personalized treatment plans based on specific biomarkers detected through immunohistochemistry. Significant improvements in staining techniques and emerging technologies improve the accuracy and efficiency of disease diagnosis. The growing research activities require detailed cellular analysis, promoting the use of immunohistochemistry in understanding disease mechanisms and pathology. This is further driving the demand for diagnostics in the immunohistochemistry market growth.

Breakup by End-Use:

  • Hospitals and Diagnostic Laboratories
  • Research Institutes
  • Others

Hospitals and Diagnostic Laboratories represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the end-use. This includes hospitals and diagnostic laboratories, research institutes, and others. According to the report, hospitals and diagnostic laboratories represented the largest segment.

The rising rates of chronic diseases particularly cancers, are driving the demand for precise diagnostic tools such as immunohistochemistry to accurately identify and classify disease states. Significant innovations in digital imaging systems and staining techniques enhance the diagnostic capabilities and throughput of immunohistochemistry, making it more appealing for clinical settings. The rising focus on adherence to high quality and regulatory standards in diagnostic processes necessitates reliable techniques like immunohistochemistry. The increasing investments in healthcare infrastructure and diagnostic services boost the adoption of advanced diagnostic methods, such as immunohistochemistry, in both developed and emerging markets.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest immunohistochemistry market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for immunohistochemistry.

The rising cases of cancer and other chronic conditions are driving the demand for precise diagnostic methods like immunohistochemistry to identify biomarkers for effective treatment which is influencing the market growth across the region. The well-established healthcare facilities and robust funding research and development (R&D) are facilitating the adoption of advanced diagnostic technologies. According to the data from the National Library of Medicine, in 2024, 2,001,140 new cancer cases and 611,720 cancer deaths are projected to occur in the United States. Cancer mortality continued to decline through 2021, averting over 4 million deaths since 1991 because of reductions in smoking, earlier detection for some cancers, and improved treatment options in both adjuvant and metastatic settings.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the immunohistochemistry industry include Abcam plc, Agilent Technologies Inc., Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, Bio SB Inc., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, Merck KGaA, Perkinelmer Inc. and Thermo Fisher Scientific Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

  • The market is highly competitive, with key players like Agilent Technologies, Thermo Fisher Scientific, and Roche Diagnostics dominating. These players focus on innovation and strategic partnerships to enhance their product portfolios. Other significant companies such as Merk Group, Bio-Rad Laboratories, and Danaher Corporation, emphasize expanding their global footprints through collaborations and acquisitions. In February 2023, Agilent Technologies Inc. introduced an integrated solution that combines their xCELLigence RTCA HT platform with the Bio Tek BioSpa 8 Automated Incubator. This new development offers a higher level of workflow automation, allowing further creation of label-free high throughput potency assays for immune-oncology and high throughput viral cytopathic effects (CPE) assays for the vaccine market.

Immunohistochemistry Market News:

  • In August 2023, global science and technology provider Danaher signed the definitive agreement for the acquisition of all outstanding stakes in UK-based protein consumables supplier Abcam in a deal valued at $5.7 bn.
  • In January 2024, Agilent Technologies Inc. announced an agreement with Incyte that will bring together Agilent's expertise and proven track record in the development of companion diagnostics (CDx) to support the development of commercialization of Incyte's hematology and oncology portfolio.
  • In June 2022, Merck, a leading science and technology company, announced that it has entered a collaboration with Agilent Technologies to advance Process Analytical Technologies (PAT). PAT, which is strongly encouraged by global regulatory authorities, is a key enabler for real-time release and Bioprocessing 4.0.

Key Questions Answered in This Report:

  • How has the global immunohistochemistry market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global immunohistochemistry market?
  • What is the impact of each driver, restraint, and opportunity on the global immunohistochemistry market?
  • What are the key regional markets?
  • Which countries represent the most attractive immunohistochemistry market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the immunohistochemistry market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the immunohistochemistry market?
  • What is the breakup of the market based on the end-use?
  • Which is the most attractive end-use in the immunohistochemistry market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global immunohistochemistry market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Immunohistochemistry Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Antibodies
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Primary Antibodies
      • 6.1.2.2 Secondary Antibodies
    • 6.1.3 Market Forecast
  • 6.2 Equipment
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Slide Staining Systems
      • 6.2.2.2 Tissue Microarrays
      • 6.2.2.3 Tissue Processing Systems
      • 6.2.2.4 Slide Scanners
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast
  • 6.3 Reagents
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Histological Stains
      • 6.3.2.2 Blocking sera and Reagents
      • 6.3.2.3 Chromogenic Substrates
      • 6.3.2.4 Fixation Reagents
      • 6.3.2.5 Stabilizers
      • 6.3.2.6 Organic Solvents
      • 6.3.2.7 Proteolytic Enzymes
      • 6.3.2.8 Diluents
    • 6.3.3 Market Forecast
  • 6.4 Kits
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Diagnostics
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Cancer
      • 7.1.2.2 Infectious Diseases
      • 7.1.2.3 Cardiovascular Diseases
      • 7.1.2.4 Autoimmune Diseases
      • 7.1.2.5 Diabetes Mellitus
      • 7.1.2.6 Nephrological Diseases
    • 7.1.3 Market Forecast
  • 7.2 Drug Testing
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Hospitals and Diagnostic Laboratories
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Research Institutes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abcam plc
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Agilent Technologies Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Beckman Coulter Inc. (Danaher Corporation)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Becton Dickinson and Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Bio SB Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Bio-Rad Laboratories Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Bio-Techne Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Cell Signaling Technology Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 F. Hoffmann-La Roche AG
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 SWOT Analysis
    • 14.3.10 Merck KGaA
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Perkinelmer Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Thermo Fisher Scientific Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Immunohistochemistry Market: Major Drivers and Challenges
  • Figure 2: Global: Immunohistochemistry Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Immunohistochemistry Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Immunohistochemistry Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Immunohistochemistry Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Immunohistochemistry Market: Breakup by End Use (in %), 2023
  • Figure 7: Global: Immunohistochemistry Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Immunohistochemistry (Antibodies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Immunohistochemistry (Antibodies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Immunohistochemistry (Equipment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Immunohistochemistry (Equipment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Immunohistochemistry (Reagents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Immunohistochemistry (Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Immunohistochemistry (Kits) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Immunohistochemistry (Kits) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Immunohistochemistry (Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Immunohistochemistry (Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Immunohistochemistry (Drug Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Immunohistochemistry (Drug Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Immunohistochemistry (Hospitals and Diagnostic Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Immunohistochemistry (Hospitals and Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Immunohistochemistry (Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Immunohistochemistry (Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Immunohistochemistry (Other End Uses) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Immunohistochemistry (Other End Uses) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: North America: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: North America: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: United States: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: United States: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Canada: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Canada: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Asia-Pacific: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Asia-Pacific: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: China: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: China: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Japan: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Japan: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: India: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: India: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: South Korea: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: South Korea: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Australia: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Australia: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Indonesia: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Indonesia: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Others: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Others: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Europe: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Europe: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Germany: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Germany: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: France: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: France: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: United Kingdom: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: United Kingdom: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Italy: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Italy: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Spain: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Spain: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Russia: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Russia: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Others: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Others: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Latin America: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Latin America: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Brazil: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Brazil: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Mexico: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Mexico: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Middle East and Africa: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Middle East and Africa: Immunohistochemistry Market: Breakup by Country (in %), 2023
  • Figure 74: Middle East and Africa: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Global: Immunohistochemistry Industry: SWOT Analysis
  • Figure 76: Global: Immunohistochemistry Industry: Value Chain Analysis
  • Figure 77: Global: Immunohistochemistry Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Immunohistochemistry Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Immunohistochemistry Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Immunohistochemistry Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Immunohistochemistry Market Forecast: Breakup by End Use (in Million US$), 2024-2032
  • Table 5: Global: Immunohistochemistry Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Immunohistochemistry Market: Competitive Structure
  • Table 7: Global: Immunohistochemistry Market: Key Players